found that the slope of the ventilatory response to hypoxia decreased almost twofold from 10.4 ± 3.02 to 4.06 ± 0.86 mL min −1 mmHg −1 (-61 %) 90 min after administration of IL-1β (p < 0.05).
Abstract:
We investigated the effect of the major inflammatory cytokine interleukin-1beta (IL-1β) on the ventilatory response to hypoxia. The goal was to test the hypothesis that IL-1β impairs the hypoxic ventilatory response in vivo by indirectly inhibiting respiratory neurons in the brainstem via prostaglandins. Thus, IL-1β was delivered by cerebroventricular injection, and the ventilatory hypoxic response was assessed in anesthetized, spontaneously breathing rats pretreated with or without diclofenac, a nonspecific inhibitor of prostaglandin synthesis. We found that the slope of the ventilatory response to hypoxia decreased almost twofold from 10.4 ± 3.02 to 4.06 ± 0.86 mL min −1 mmHg −1 (-61 %) 90 min after administration of IL-1β (p < 0.05).
The slope of tidal volume and mean inspiratory flow also decreased from 0.074 ± 0.02 to 0.039 ± 0.01 mL mmHg −1 (-45 %, p < 0.05), and from 0.36 ± 0.07 to 0.2 ± 0.04 mL s −1 mmHg −1 (-46 %, D r a f t
Introduction
Accumulating evidence now suggest that systemic inflammation modulates ventilatory control, the key elements of which include the hypoxic and hypercapnic respiratory chemoreflexes. These elements maintain the homeostasis of gases in arterial blood. In previous studies, we demonstrated that elevated levels of the major inflammatory cytokine interleukin-1β
(IL-1β) in the cerebrospinal fluid reduces the sensitivity of the central chemoreflex to carbon dioxide, and that prostaglandins mediate the effects of IL-1β on the hypercapnic response (Aleksandrova and Danilova 2010; Aleksandrova et al. 2015) . Intravenous injection of lipopolysaccharide, and the subsequent release of inflammatory cytokines, were also reported to repress the ventilatory response to hypoxia (Fernandez et al. 2008; Zapata et al. 2011 The hypoxic ventilatory response arises predominantly from peripheral arterial chemoreceptors in the carotid body. Notably, Lam et al. (2008) found that systemic inflammation causes morphological changes in the carotid body. Such changes are associated with changes in the levels inflammatory cytokines, and reduce the chemosensitivity to hypoxia (Gauda et al. 2013) . Moreover, glomus cells, which are the primary O 2 -sensing elements in the carotid body (Zhang et al. 2007 ), express IL-1 receptor type I and IL-6 receptor α even under normoxic conditions (Wang et al. 2002 (Wang et al. , 2006 . These cells can depolarize in response to hypoxia and release neurotransmitters that activate sensory nerve fibers terminating in the brainstem respiratory center. Taken together, these observations indicate that the carotid body has immunosensory activity, and may modulate the hypoxic ventilatory response during inflammation.
However, a central component in the brainstem complements the peripheral component of the hypoxic chemoreflex. Thus, inflammation-related functional changes in brainstem D r a f t respiratory neurons may also evoke changes in the hypoxic ventilatory response. Indeed, has been shown to induce expression of c-fos, a marker of functionally activated neurons, in respiration-related regions in the brainstem, including the nucleus tractus solitarius (Ericsson et al. 1997) . However, the nucleus tractus solitarius has been reported to not express IL-1 receptors, and brainstem respiration-related neurons were found to be insensitive to IL-1β in vitro (Olsson et al. 2003) . We now present evidence that IL-1β may impair the central hypoxic ventilatory response in vivo through indirect suppression of respiratory neurons in the brainstem via
prostaglandins. This phenomenon is demonstrated in anesthetized, spontaneously breathing rats injected with IL-1β, and which were pretreated with or without diclofenac, a nonspecific inhibitor of prostaglandin synthesis.
Materials and methods

Experiments
Data were collected from 36 tracheostomized rats with mean weight 270 ± 10 g, and which were anesthetized intraperitoneally with 1000 mg kg −1 urethane, a level sufficient to eliminate pain reflexes. Anesthetic depth was monitored by corneal reflex and response to tactile stimuli. The anaesthetized rats were placed in a stereotactic frame in the supine position with a fixed head. The skin and connective tissues were removed from the skull, a hole was drilled, and a microinjection cannula was placed into the right ventricle of the brain. The stereotaxic coordinates were as follows: 0.8 mm posterior to bregma, 1.5 mm lateral from the midline, and 3.7 mm below the surface of the scull (Paxinos and Watson 1982 
D r a f t Ventilation and alveolar gases
A respiratory flow head connected to a pneumotachometer (AD Instruments ML141
Spirometer, Dunedin, New Zealand) was used to measure peak airflow and respiratory rate.
Airflow was integrated to obtain respiratory volume. Minute ventilation was calculated from mean tidal volume and respiratory frequency of ten respiratory cycles, while mean inspiratory flow was calculated as tidal volume divided by inspiratory time. End-tidal partial pressure of oxygen (P ET O 2 ) was analyzed by a rapid-response quadruple mass spectrometer (Model МC-100, Institute for Analytical Instrumentation, Saint Petersburg, Russia), which was calibrated immediately before and after use with onboard gas mixtures of known composition.
Ventilatory response to hypoxia
Hypoxic ventilatory response was measured using isocapnic progressive hypoxia rebreathing, following Read (1967) , with some modification. 
Drug administration
The animals were divided into four groups. The animals of the first group (n=9) were administered IL-1β (350 ng of human recombinant IL-1β in10 µl of saline, Sigma) into the lateral ventricle of the brain. Animals of the second group (n=9) were first injected intraperitoneally with diclofenac (0.5 µg, Belmedpreparaty RUE, Russia) and then IL-1β.
Diclofenac, a non-specific cyclooxygenase inhibitor, was used to investigate the role of the cyclooxygenase pathway in the effects of IL-1β. The third group of animals (n=9) was the control, these animals received 10 µl of saline instead of Il-1beta. Fourth group (n=9) was used in order to find possible action of diclofenac on the carotid body. Animals included this group were administered diclofenac intraperitoneally.
The experiment lasted 120 minutes, IL-1β or saline was administered at the thirtieth minute. Diclofenac was injected on the tenth minute of the experiment, that is, 20 minutes before the administration of IL-1β, since according to official information the manufacturer the maximum content of diclofenac in blood is reached after 10-20 minutes even after injection.
Hypoxic ventilatory response was measured before microinjection of IL-1β or saline and on 20, 40, 60, and 90 min after administration.
Statistics
Data are reported as mean ± SE. Values before and after cerebroventricular injections were compared using Wilcoxon signed rank test and one-way analysis of variance for repeated measures. Differences were considered significant at p < 0.05. For statistical processing of experimental data STATISTICA 7.0 software package was used.
During hypoxia, significant correlation was observed between minute ventilation, tidal volume, mean inspiratory flow, and decrease in P ET O 2 , both before and after cerebroventricular injections of IL-1β. However, IL-1β decreased the ventilatory response to hypoxia (Fig. 1) , and flattened the hypoxic response slopes ( Fig. 2A-C 
Ventilatory response to hypoxia after diclofenac pretreatment
The effect of IL-1β on the ventilatory hypoxic response was blocked in rats pretreated with diclofenac, a nonspecific cyclooxygenase inhibitor (Fig. 1) . In particular, IL-1β did not significantly change either the position or the slope of the ventilation-P ET O 2 line when administered after an intraperitoneal injection of diclofenac ( Fig. 2D-F) . Similarly, the relationship between P ET O 2 and tidal volume or mean inspiratory flow did not significantly change from baseline (Fig. 3) .
Discussion
The data demonstrate a marked attenuation in the hypoxic ventilatory response after cerebral IL-1β is artificially elevated in anesthetized rats. Thus, IL-1β appears to modulate not We also now demonstrate that cerebral IL-1β depresses the hypoxic chemoreflex via cyclooxygenase, indicating that endogenous prostaglandins may modulate brainstem respiratory neurons during hypoxia, in line with previous studies. For example, IL-1β is already known to D r a f t elicit cyclooxygenase activity and release of multiple secondary mediators, including prostaglandins. Further, Graff and Gozal (1999) reported that IL-1β induces ventilatory effects via eicosanoid-dependent mechanisms. Similarly, we previously demonstrated that inhibiting prostaglandin synthesis with diclofenac clearly blocks the effects of IL-1β on breathing patterns and on the hypercapnic ventilatory response in adult rats (Aleksandrova et al. 2015) . PGE 2 has also been shown to mediate the anoxic ventilatory effects of IL-1β, while indomethacin has been shown to mitigate the adverse effects of IL-1β on hypoxic gasping and anoxic survival in neonatal rats (Hofstetter et al. 2007; Olsson et al. 2003) . In addition, it was shown that intravenous administration of endotoxin not only elicited release of inflammatory cytokines, but also altered the respiratory motor output and the cyclooxygenase pathway (Preas et al. 2001 ).
Stimulation of prostaglandin synthesis appears to be a fundamental and specific mechanism by which IL-1β modulates neuronal function, including in respiration. For instance, IL-1β induces release of cyclooxygenase-2 and PGE 2 in glial and neuronal ganglion cells cultured from rat trigeminal ganglia (Neeb et al. 2011) . Our own experiments with diclofenac suggest that IL-1β depends on a similar mechanism to elicit respiratory effects in the brainstem, presumably via glial and neural cells in respiration-related units and that express receptors for IL-1. Upon stimulation, these cells would release prostaglandins into the extracellular space, and thereby stimulate neurons with PGE 2 receptors such as EP3R. Indeed, EP3R is strongly expressed in respiration-related tissues of the brainstem such as the NTS and RVLM (Ek et al.
D r a f t
injection of PGE 2 evokes selective and specific expression of c-fos in brain structures that regulate respiration. In our own experiments, the hypoxic response also degraded within 30-40 minutes after intraventricular administration of IL-1β.
In conclusion, IL-1β appears to be an intercellular messenger molecule that links central and peripheral ventilatory control to immune activity. In particular, IL-1β suppresses respiratory chemoreflexes by inducing production of prostaglandins. Increase cerebral levels of this cytokine, which is induced by the activation of immune cells in the brain may impair respiratory chemoreflexes at the level of the brain stem. We also conclude that the adverse influence of IL-1β on the respiratory chemoreflexes is mediated by activation of endogenous prostaglandin production.
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